Loading...
Back to narrative

Update shared on27 Aug 2025

Fair value Decreased 2.30%
AnalystConsensusTarget's Fair Value
UK£14.50
34.6% undervalued intrinsic discount
27 Aug
UK£9.49
Loading
1Y
-5.5%
7D
-3.5%

Despite a sharp increase in revenue growth forecasts, a notable decline in net profit margin has led to a slight reduction in Burford Capital’s consensus analyst price target from £14.84 to £14.50.


What's in the News


  • Burford Capital added to multiple Russell growth indices, including the Russell 2000, 2500, 3000, Small Cap Comp, and 3000E Growth indices.
  • The company commenced a share buyback program with authorization to repurchase up to 21,942,190 shares (10% of issued share capital), with flexible terms regarding price and disposal of repurchased shares.

Valuation Changes


Summary of Valuation Changes for Burford Capital

  • The Consensus Analyst Price Target has fallen slightly from £14.84 to £14.50.
  • The Consensus Revenue Growth forecasts for Burford Capital has significantly risen from 12.4% per annum to 31.0% per annum.
  • The Net Profit Margin for Burford Capital has significantly fallen from 58.23% to 49.92%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.